Suppr超能文献

细胞脱离通过细胞骨架重排激活 Hippo 通路,从而诱导细胞凋亡。

Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis.

机构信息

Life Sciences Institute, Zhejiang University, Hangzhou, Zhejiang, China.

出版信息

Genes Dev. 2012 Jan 1;26(1):54-68. doi: 10.1101/gad.173435.111.

Abstract

Cell attachment to the extracellular matrix (ECM) is crucial to cell physiology such as polarity, motility, and proliferation. In normal cells, loss of attachment to the ECM induces a specific type of apoptosis, termed anoikis. Resistance to anoikis in cancer cells promotes their survival in circulation and dispersion to distant anatomic sites, leading to tumor metastasis. The Yes-associated protein (YAP) transcription coactivator is a human oncogene and a key regulator of organ size. The Hippo tumor suppressor pathway phosphorylates and inhibits YAP. However, little is known about the signals that regulate the Hippo pathway. Here we report that through cytoskeleton reorganization, cell detachment activates the Hippo pathway kinases Lats1/2 and leads to YAP phosphorylation and inhibition. The detachment-induced YAP inactivation is required for anoikis in nontransformed cells, whereas in cancer cells with deregulation of the Hippo pathway, knockdown of YAP and TAZ restores anoikis. Furthermore, we provided evidence that Lats1/2 expression level is indeed significantly down-regulated in metastatic prostate cancer. Our findings provide a novel connection between cell attachment and anoikis through the Hippo pathway and have important implications in cancer therapeutics.

摘要

细胞与细胞外基质(ECM)的附着对于细胞生理学至关重要,如极性、运动性和增殖。在正常细胞中,与 ECM 的附着丧失会诱导一种特定类型的细胞凋亡,称为失巢凋亡。癌细胞对失巢凋亡的抵抗力促进了它们在循环中的存活和向远处解剖部位的扩散,导致肿瘤转移。Yes 相关蛋白(YAP)转录共激活因子是一种人类癌基因,也是器官大小的关键调节因子。Hippo 肿瘤抑制途径磷酸化并抑制 YAP。然而,对于调节 Hippo 途径的信号知之甚少。在这里,我们报告说,通过细胞骨架重组,细胞脱落后激活 Hippo 途径激酶 Lats1/2,并导致 YAP 磷酸化和抑制。失巢凋亡中非转化细胞中需要脱附诱导的 YAP 失活,而在 Hippo 途径失调的癌细胞中,敲低 YAP 和 TAZ 可恢复失巢凋亡。此外,我们提供了证据表明,在转移性前列腺癌中,Lats1/2 的表达水平确实显著下调。我们的发现通过 Hippo 途径提供了细胞附着与失巢凋亡之间的新联系,并对癌症治疗具有重要意义。

相似文献

1
Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis.
Genes Dev. 2012 Jan 1;26(1):54-68. doi: 10.1101/gad.173435.111.
2
Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs).
Genes Dev. 2012 Oct 1;26(19):2138-43. doi: 10.1101/gad.197582.112. Epub 2012 Sep 12.
3
Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein.
Genes Dev. 2011 Jan 1;25(1):51-63. doi: 10.1101/gad.2000111.
4
Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
Small GTPases. 2020 Jul;11(4):280-288. doi: 10.1080/21541248.2018.1435986. Epub 2018 Apr 20.
5
A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.
Genes Dev. 2015 Jun 15;29(12):1271-84. doi: 10.1101/gad.262816.115.
8
MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway.
J Biol Chem. 2021 Jan-Jun;296:100400. doi: 10.1016/j.jbc.2021.100400. Epub 2021 Feb 9.
9
Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1.
Cancer Res. 2017 Sep 15;77(18):4868-4880. doi: 10.1158/0008-5472.CAN-17-0391. Epub 2017 Jul 28.

引用本文的文献

2
Pipeline to evaluate YAP-TEAD inhibitors indicates TEAD inhibition represses -mutant mesothelioma.
Life Sci Alliance. 2025 Jul 31;8(10). doi: 10.26508/lsa.202503241. Print 2025 Oct.
3
Targeting cancer cell stiffness and metastasis with clinical therapeutics.
Clin Exp Metastasis. 2025 Jun 11;42(4):34. doi: 10.1007/s10585-025-10353-2.
5
Identification of YAP regulators through high-throughput screening and NanoBiT-based validation-drug repositioning for cancer therapy.
Anim Cells Syst (Seoul). 2025 May 8;29(1):325-338. doi: 10.1080/19768354.2025.2489389. eCollection 2025.
9
The STRIPAK complex is required for radial sorting and laminin receptor expression in Schwann cells.
Cell Rep. 2025 Mar 25;44(3):115401. doi: 10.1016/j.celrep.2025.115401. Epub 2025 Mar 6.
10
Regulation of Hippo-YAP1/TAZ pathway in metabolic dysfunction-associated steatotic liver disease.
Front Pharmacol. 2025 Jan 23;16:1505117. doi: 10.3389/fphar.2025.1505117. eCollection 2025.

本文引用的文献

1
Hippo pathway regulation by cell morphology and stress fibers.
Development. 2011 Sep;138(18):3907-14. doi: 10.1242/dev.070987. Epub 2011 Aug 10.
2
E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components.
Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):11930-5. doi: 10.1073/pnas.1103345108. Epub 2011 Jul 5.
3
Role of YAP/TAZ in mechanotransduction.
Nature. 2011 Jun 8;474(7350):179-83. doi: 10.1038/nature10137.
5
Modulating F-actin organization induces organ growth by affecting the Hippo pathway.
EMBO J. 2011 May 10;30(12):2325-35. doi: 10.1038/emboj.2011.157.
6
Actin-Capping Protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila.
Development. 2011 Jun;138(11):2337-46. doi: 10.1242/dev.063545. Epub 2011 Apr 27.
7
Yap1 acts downstream of α-catenin to control epidermal proliferation.
Cell. 2011 Mar 4;144(5):782-95. doi: 10.1016/j.cell.2011.02.031.
9
Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin.
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2270-5. doi: 10.1073/pnas.1019603108. Epub 2011 Jan 24.
10
Hippo pathway-independent restriction of TAZ and YAP by angiomotin.
J Biol Chem. 2011 Mar 4;286(9):7018-26. doi: 10.1074/jbc.C110.212621. Epub 2011 Jan 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验